Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Jan;51(1):110–116.

Asbestos exposure correlates with alterations in circulating T cell subsets.

L G Miller, D Sparrow, L C Ginns
PMCID: PMC1536754  PMID: 6600988

Abstract

Peripheral blood lymphocytes were analysed from 40 subjects with occupational asbestos exposure and 40 controls matched for age and smoking habits. Patients were classified by duration of exposure as short or long, and by chest radiograph as normal, pleural plaques or interstitial changes. As a group, subjects with asbestos exposure had decreased percentages of OKT3+ and OKT8+ cells and increased OKT4+/OKT8+ ratio compared to controls. Correcting for age and smoking, those with short exposure were similar to controls, while those with long exposure had decreased percentages OKT3+ and OKT8+ cells and an increased OKT4+/OKT8+ ratio. Among radiographic subgroups, those with normal radiographs were similar to controls, but those with plaques had increased circulating OKT4+ cells, and those with interstitial changes had decreased percentages OKT3+ and OKT8+ cells and OKT8+ cells/mm3, with an increased OKT4+/OKT8+ ratio. There were no differences between subjects and controls in OKT10+ cells and OKIa+ cells. There appears to be a progressive decrease in percentage OKT8+ cells and increase in OKT4+/OKT8+ ratio with increasing exposure to asbestos, as determined by length of exposure and by radiographic abnormalities.

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bader M. E., Bader R. A., Teirstein A. S., Miller A., Selikoff I. J. Pulmonary function and radiographic changes in 598 workers with varying duration of exposure to asbestos. Mt Sinai J Med. 1970 Jul-Aug;37(4):492–500. [PubMed] [Google Scholar]
  2. Becklake M. R. Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am Rev Respir Dis. 1976 Jul;114(1):187–227. doi: 10.1164/arrd.1976.114.1.187. [DOI] [PubMed] [Google Scholar]
  3. Breard J., Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol. 1980 Apr;124(4):1943–1948. [PubMed] [Google Scholar]
  4. Broder S., Uchiyama T., Muul L. M., Goldman C., Sharrow S., Poplack D. G., Waldmann T. A. Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells. N Engl J Med. 1981 Jun 4;304(23):1382–1387. doi: 10.1056/NEJM198106043042302. [DOI] [PubMed] [Google Scholar]
  5. Campbell M. J., Wagner M. M., Scott M. P., Brown D. G. Sequential immunological studies in an asbestos-exposed population. II. Factors affecting lymphocyte function. Clin Exp Immunol. 1980 Jan;39(1):176–182. [PMC free article] [PubMed] [Google Scholar]
  6. Friedman S. M., Hunter S. B., Irigoyen O. H., Kung P. C., Goldstein G., Chess L. Functional analysis of human T cell subsets defined by monoclonal antibodies. II. Collaborative T-T interactions in the generation of TNP-altered-self-reactive cytotoxic T lymphocytes. J Immunol. 1981 May;126(5):1702–1705. [PubMed] [Google Scholar]
  7. Gaumer H. R., Doll N. J., Kaimal J., Schuyler M., Salvaggio J. E. Diminished suppressor cell function in patients with asbestosis. Clin Exp Immunol. 1981 Apr;44(1):108–116. [PMC free article] [PubMed] [Google Scholar]
  8. Ginns L. C., Goldenheim P. D., Miller L. G., Burton R. C., Gillick L., Colvin R. B., Goldstein G., Kung P. C., Hurwitz C., Kazemi H. T-lymphocyte subsets in smoking and lung cancer: Analysis of monoclonal antibodies and flow cytometry. Am Rev Respir Dis. 1982 Aug;126(2):265–269. doi: 10.1164/arrd.1982.126.2.265. [DOI] [PubMed] [Google Scholar]
  9. Haslam P. L., Lukoszek A., Merchant J. A., Turner-Warwick M. Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. Clin Exp Immunol. 1978 Feb;31(2):178–188. [PMC free article] [PubMed] [Google Scholar]
  10. Haslam P. L., Turton C. W., Heard B., Lukoszek A., Collins J. V., Salsbury A. J., Turner-Warwick M. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax. 1980 Jan;35(1):9–18. doi: 10.1136/thx.35.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hoffman R. A., Kung P. C., Hansen W. P., Goldstein G. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4914–4917. doi: 10.1073/pnas.77.8.4914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hunninghake G. W., Crystal R. G. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med. 1981 Aug 20;305(8):429–434. doi: 10.1056/NEJM198108203050804. [DOI] [PubMed] [Google Scholar]
  13. Huuskonen M. S., Räsänen J. A., Härkönen H., Asp S. Asbestos exposure as a cause of immunological stimulation. Scand J Respir Dis. 1978;59(6):326–332. [PubMed] [Google Scholar]
  14. Kagan E., Solomon A., Cochrane J. C., Beissner E. I., Gluckman J., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity. Clin Exp Immunol. 1977 May;28(2):261–267. [PMC free article] [PubMed] [Google Scholar]
  15. Kagan E., Solomon A., Cochrane J. C., Kuba P., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity. Clin Exp Immunol. 1977 May;28(2):268–275. [PMC free article] [PubMed] [Google Scholar]
  16. Kang K., Sera Y., Okochi T., Yamamura Y. Letter: T lymphocytes in abestosis. N Engl J Med. 1974 Oct 3;291(14):735–736. doi: 10.1056/NEJM197410032911414. [DOI] [PubMed] [Google Scholar]
  17. Kung P. C., Goldstein G. Functional and developmental compartments of human T lymphocytes. Vox Sang. 1980 Sep;39(3):121–127. doi: 10.1111/j.1423-0410.1980.tb01846.x. [DOI] [PubMed] [Google Scholar]
  18. Kung P., Goldstein G., Reinherz E. L., Schlossman S. F. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979 Oct 19;206(4416):347–349. doi: 10.1126/science.314668. [DOI] [PubMed] [Google Scholar]
  19. Lange A. An epidemiological survey of immunological abnormalities in asbestos workers. I. Nonorgan and organ-specific autoantibodies. Environ Res. 1980 Jun;22(1):162–175. doi: 10.1016/0013-9351(80)90128-0. [DOI] [PubMed] [Google Scholar]
  20. Lange A. An epidemiological survey of immunological abnormalities in asbestos workers. II. Serum immunoglobulin levels. Environ Res. 1980 Jun;22(1):176–183. doi: 10.1016/0013-9351(80)90129-2. [DOI] [PubMed] [Google Scholar]
  21. McMillan G. H., Rossiter C. E. Development of radiological and clinical evidence of parenchymal fibrosis in men with non-malignant asbestos-related pleural lesions. Br J Ind Med. 1982 Feb;39(1):54–59. doi: 10.1136/oem.39.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. O'Malley J. A., Nussbaum-Blumenson A., Sheedy D., Grossmayer B. J., Ozer H. Identification of the T cell subset that produces human gamma interferon. J Immunol. 1982 Jun;128(6):2522–2526. [PubMed] [Google Scholar]
  23. Ortaldo J. R., Sharrow S. O., Timonen T., Herberman R. B. Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol. 1981 Dec;127(6):2401–2409. [PubMed] [Google Scholar]
  24. Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reinherz E. L., Kung P. C., Pesando J. M., Ritz J., Goldstein G., Schlossman S. F. Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med. 1979 Dec 1;150(6):1472–1482. doi: 10.1084/jem.150.6.1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  27. Rola-Pleszczynski M., Massé S., Sirois P., Lemaire I., Bégin R. Early effects of low-doses exposure to asbestos on local cellular immune responses in the lung. J Immunol. 1981 Dec;127(6):2535–2538. [PubMed] [Google Scholar]
  28. Thomas Y., Rogozinski L., Irigoyen O. H., Friedman S. M., Kung P. C., Goldstein G., Chess L. Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population. J Exp Med. 1981 Aug 1;154(2):459–467. doi: 10.1084/jem.154.2.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Verbi W., Greaves M. F., Schneider C., Koubek K., Janossy G., Stein H., Kung P., Goldstein G. Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors". Eur J Immunol. 1982 Jan;12(1):81–86. doi: 10.1002/eji.1830120115. [DOI] [PubMed] [Google Scholar]
  30. Wagner M. M., Campbell M. J., Edwards R. E. Sequential immunological studies on an asbestos-exposed population. I. Factors affecting peripheral blood leucocytes and T lymphocytes. Clin Exp Immunol. 1979 Nov;38(2):323–331. [PMC free article] [PubMed] [Google Scholar]
  31. Wagner M. M. Immunology and asbestos. IARC Sci Publ. 1980;(30):247–251. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES